Cogent Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
1.51 |
32.29 |
201.58 |
339.30 |
586.53 |
| Przychód Δ r/r |
0.00% |
inf% |
2032.21% |
524.29% |
68.32% |
72.87% |
| Przychód (min) |
0.00 |
1.51 |
30.61 |
193.89 |
339.30 |
586.53 |
| Przychód (max) |
0.00 |
1.51 |
33.96 |
209.27 |
339.30 |
586.53 |
| EBITDA (średnia) |
0.00 |
0.91 |
19.37 |
120.95 |
203.58 |
351.92 |
| EBIT (średnia) |
0.00 |
0.91 |
19.37 |
120.95 |
203.58 |
351.92 |
| EBIT % |
0.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-250.19 |
-226.21 |
-277.04 |
-88.63 |
-30.76 |
64.13 |
| Zysk netto % |
-inf% |
-14937.63% |
-857.98% |
-43.97% |
-9.07% |
10.93% |
| EPS (średnia) |
-2.42 |
-2.18 |
-1.91 |
-0.83 |
-0.30 |
0.62 |
| Liczba analityków (Przychody) |
0 |
6 |
11 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
8 |
8 |
10 |
8 |
7 |
6 |
| symbol |
COGT |
COGT |
COGT |
COGT |
COGT |
COGT |